Teladoc Health, Inc. (0LDR.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.23B |
| Enterprise Value | 1.49B |
| P/E Ratio | -7.81 |
| PEG Ratio | -0.07 |
| Price/Sales Ratio | 0.54 |
| Price/Book Ratio | 1.02 |
| Enterprise/Revenue | 0.66 |
| Enterprise/EBITDA | 28.89 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.07 |
| Operating Margin | -0.08 |
| Return On Assets | -0.06 |
| Return On Equity | -0.12 |
| Revenue | 2.53B |
| Revenue/Share | 14.04 |
| Gross Profit | 1.39B |
| EBITDA | 213.04M |
| Net Income | -200.32M |
| Diluted EPS | -1.14 |
| Total Cash | 750.74M |
| Total Cash/Share | 4.19 |
| Total Debt | 1.04B |
| Total Debt/Equity | 0.78 |
| Current Ratio | 2.8 |
| Book Value Per Share | 7.46 |
| 52-Week Change | 6.17 |
| 52-Week High | 30.38 |
| 52-Week Low | 7.69 |
| Moving Average 50 Days | 18.78 |
| Moving Average 200 Days | 20.8 |
| Average Volume | 19,437 |
| Shares Outstanding | 177.46M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |